Jian Pan
Suzhou, 215025, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
NeuroD1-USP1-MYCN axis drives tumor progression in neuroblastoma.
Journal: Journal of translational medicine
Published: October 07, 2025
Microarray Identification of Differential lncRNA AC002454.1 Expression in Pediatric Acute Leukemia and Its Oncogenic Effect in Leukemia Cells in vitro.
Journal: Annals of clinical and laboratory science
Published: September 17, 2025
Targeting super-enhancer-driven MAB21L2 suppresses neuroblastoma growth and migration.
Journal: Experimental cell research
Published: July 08, 2025
KIF11 promotes AML progression, and its inhibition by SB-743921 suppresses disease advancement through mitotic G2/M phase arrest.
Journal: Cellular signalling
Published: June 03, 2025
Super-enhancer-driven ELOVL5 promotes T-ALL progression through the MYC-SERBP1 pathway.
Journal: Genomics
Published: June 03, 2025
Exploring FAM13A-N-Myc interactions to uncover potential targets in MYCN-amplified neuroblastoma: a study of protein interactions and molecular dynamics simulations.
Journal: BMC cancer
Published: November 14, 2024
Involvement of USP7 in aggravating Kawasaki disease by promoting TGFβ2 signaling mediated endothelial-mesenchymal transition and coronary artery remodeling.
Journal: International immunopharmacology
Published: November 05, 2024
IRF1 is a core transcriptional regulatory circuitry member promoting AML progression by regulating lipid metabolism.
Journal: Experimental hematology & oncology
Published: September 03, 2024
Targeting RBM39 through indisulam induced mis-splicing of mRNA to exert anti-cancer effects in T-cell acute lymphoblastic leukemia.
Journal: Journal of experimental & clinical cancer research : CR
Published: April 24, 2024
Enhancer looping protein LDB1 modulates MYB expression in T-ALL cell lines in vitro by cooperating with master transcription factors.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 28, 2024
METTL14 promotes neuroblastoma formation by inhibiting YWHAH via an m6A-YTHDF1-dependent mechanism.
Journal: Cell death discovery
Published: January 14, 2024
Last Updated: 09/26/2026